Esophageal Cancer Market Segmentation and Analysis by Recent Trends, Development and Growth by Regions to 2023
Research Reports
Jan 15, 2021
The Esophageal is the tube-like structure that connects the mouth to the stomach and helps to get foods and liquid. Esophageal cancer develops uncontrolled cancerous cells anywhere along the esophagus. Esophageal cancer considers the sixth most common cause of cancer deaths around the globe. The disease is characterized by a disordered and deregulated cellular and stromal explosion along with reduced cell death and growth factor deprivation and other factors.
Considering all these factors the market for esophageal cancer is expected to reach $ 1000.1 million by the end of 2023, this market is projected to growing at a CAGR of ~ 8.7 % during 2017-2023.
Rated the sixth most common type of cancer affecting patients, esophageal cancer is responsible for numerous deaths worldwide. Tobacco and alcohol consumption or certain dietary habits can lead to probabilities of attaining the disease. With advances in treatment, diagnostics, and surgical techniques, the prognosis rate of esophageal cancer has improved considerably over the years.
Competitive Landscape
Amgen Inc. (U.S.), Boehringer Ingelheim GmbH (Germany), Johnson & Johnson (U.S.), Eli Lilly and Company (U.S.), Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche (Switzerland), Novartis AG (Switzerland), GlaxoSmithKline Plc. (U.K), Bristol-Myers Squibb (U.S.), Bristol-Myers Squibb Company (U.S.), and Gilead Sciences, Inc. (U.S.) are the eminent players in the global esophageal cancer market.
Request for Free Sample Copy of Report:https://www.marketresearchfuture.com/sample_request/3280
Companies are continuously inventing new treatments to capture the global market. Thus players invest more in merger and acquisition activities. In this regards, Leap Therapeutics, Inc. announced the completion of its merger with Macrocure Ltd. This acquisition provide access to Macrocure for Leap Therapeutics’ pipeline candidates – DKN-01 and TRX518.These companies are more investing in research and development program to provide the best treatment option, which help them to keep ahead with their competitor.
Regional Analysis
Region-wise, the esophageal cancer market has been segmented into North America, the Middle East & Africa (MEA), Asia Pacific (APAC), and Europe.
With numerous cases of esophageal cancer, North America has commanded the leading position in the global esophageal cancer market. The population of the region is highly addicted to tobacco, which remains among the prime causes of esophageal cancer. High government support, high healthcare expenditure, and a favorable reimbursement landscape is providing impetus to the growth of the North America market. The US has major contribution to make in the North America market. Robust healthcare infrastructure and the presence of a wide population base supports the growth of the market.
Intensive R&D activities in Europe is driving the growth of the esophageal cancer market in Europe. The expansion of the APAC market can be attributed to the surging incidence rate of esophageal cancer and large unmet needs in the region.
Get Pre and Post Covid-19 Impact Analysis on the Market:https://www.marketresearchfuture.com/enquiry/3280
Segmentation Analysis
The global esophageal cancer market has been segmented based on type, phase, and treatment.
By type, the esophageal cancer market has been segmented into esophageal squamous-cell carcinoma, esophageal adenocarcinoma, and others. The esophageal squamous-cell carcinoma segment is predicted to gain significant revenue in the coming years. It held close to 65% market share in 2016.
By phase, the esophageal cancer market has been segmented into phase I, phases II, and phases III.
By treatment, the esophageal cancer market has been segmented into surgery, chemotherapy and radiotherapy, and others.
Have Any Query? Connect with Our Research Expert:https://www.marketresearchfuture.com/enquiry/3280
About Us:
Market Research Future (MRFR) is a world-renowned market research company that offers a wide range of services, complete with accurate and precise analysis about diverse markets, sub-markets and target consumers. Our approach is a combination of extensive information and multiple data sources that help provide an exhaustive comprehension about the latest major developments to the client, in addition to future events and what measures and decisions to take on the basis of the same.
Our fast emerging market research firm is armed with an adept research analysts’ team that focuses on gathering useful data and analytics in terms of economic and technological advances. Our proficient analysts conduct industrial visits in a bid to achieve reliable and accurate information from established market participants. One of our foremost objectives is to keep the client well-versed with all the lucrative opportunities as well as challenges surrounding various global markets. We offer step-by-step guidance to our clients, through consulting and strategic services, enabling them to arrive at a practical and effective decision.
Tags:
, Reportedtimes, iCN Internal Distribution, Research Newswire, English
YOU MAY ALSO LIKE
PW Consulting Releases Comprehensive Market Research on…
The Esophageal is the tube-like structure that connects the mouth to the stomach and helps to get foods and liquid. Esophageal cancer develops uncontrolled cancerous…
read more